Best Value Stocks To Invest In 2018

Description of the opportunity and investment thesis

CRHM represents a compelling risk/reward opportunity in the form of a rapidly growing leader in anesthesiology services for GIs in the US and Canada. We believe the company is undervalued on an absolute and relative basis, currently trading at a dramatically low multiple of current and future estimated free cash flow. Given the companys niche position in their market, stable business model, long runway for growth, and fears surrounding short-term operational results, we feel weve been provided with a solid margin of safety at current price levels, with the chance for 100% upside or more within 12-18 months.

Best Value Stocks To Invest In 2018: Layne Christensen Company(LAYN)

Advisors’ Opinion:

  • [By Peter Graham]

    A long term performance chart shows small caps Great Lakes Dredge & Dock Corporation andLayne Christensen Company (NASDAQ: LAYN) underperforming, but possibly recovering while Orion Group Holdings (NYSE: ORN) had a clear reversal early last year:

  • [By Lisa Levin]

    Shares of Layne Christensen Company (NASDAQ: LAYN) got a boost, shooting up 16 percent to $8.78 after the company posted a narrower-than-expected loss for its first quarter.

Best Value Stocks To Invest In 2018: Knowles Corporation(KN)

Advisors’ Opinion:

  • [By Jack Delaney]

    A deal with Facebook Inc. (Nasdaq: FB) brought the little-known Knowles Corp. (NYSE: KN) to investors’ attention today, boosting Knowles Corp. stock by 2.3% as of 12:30 p.m. today (Oct. 30, 2017).

Best Value Stocks To Invest In 2018: Hudson Technologies, Inc.(HDSN)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    Finally, Cramer said Hudson Technologies (HDSN) was a great stock to own in 2016, when shares soared 170%, but this year, he cannot recommend this high-flying refrigeration company.

  • [By Lisa Levin]

    Hudson Technologies, Inc. (NASDAQ: HDSN) shares dropped 13 percent to $6.55 amid concerning guidance. The company said it is expecting Q3 EPS of $0.03-$0.05 versus an analyst consensus estimate of $0.10. Sales are expected to be around $25 million versus the analyst estimate of nearly $41 million.

Leave a Reply

Your email address will not be published. Required fields are marked *